S. Cummings

CHAPTER 1 – Metabolic Formation of Toxic Metabolites*

R. Prough, S. Cummings, 1983 .

Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes.

G. Ansari, F. Guengerich, R. Prough, 1985, Cancer research.

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

J. McQueen, G. Ashcroft, C. Yates, 1982, Psychological Medicine.

Metabolic activation of the terminal N-methyl group of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine).

R. Prough, P. Wiebkin, S. Cummings, 1985, Carcinogenesis.

Butylated hydroxyanisole-stimulated NADPH oxidase activity in rat liver microsomal fractions.

R. Prough, S. Cummings, Scott W. CummingsS, 1983, The Journal of biological chemistry.

Effect of hypoxic perfusion on hepatic concentration and biliary release of glutathione disulfide.

D. Ziegler, R. Burk, S. Cummings, 1988, Biochemical pharmacology.

Rat pancreatic kallikrein mRNA: nucleotide sequence and amino acid sequence of the encoded preproenzyme.

J. Dagorn, Raymond J MacDonald, J C Dagorn, 1982, Proceedings of the National Academy of Sciences of the United States of America.

The characterization of N-isopropyl-p-hydroxymethylbenzamide formed during the oxidative metabolism of azo-procarbazine.

F. Guengerich, R. Prough, S. Cummings, 1982, Drug metabolism and disposition: the biological fate of chemicals.

The effect of the tert-butylquinone metabolite of butylated hydroxyanisole on cytochrome P-450 monooxygenase activity.

J. Peterson, R. Prough, S. Cummings, 1990, Xenobiotica; the fate of foreign compounds in biological systems.